Project Grant R01AR087443
- Federal Project Grant Award Summary Rush University Medical Center received a $596,189 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded September 5, 2025, with a completion date of July 31, 2030. The project develops comprehensive preclinical assessment tools and testing strategies to prevent fretting-corrosion in modular junctions of total joint...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Washington University a $378,228 Project Grant on September 10, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to validate a novel preclinical rabbit model for hip pre-osteoarthritis (OA). The award, with completion scheduled for August 31, 2027, will deliver research products demonstrating the pathomechanical and...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded President and Fellows of Harvard College a $676,841 project grant effective August 1, 2025, through July 31, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The project, "Leveraging Human Musculoskeletal Development to Identify Causal Disease Variants," will deliver comprehensive transcriptomic and epigenomic mapping of human...
- Federal Project Grant Award Summary Flex Orthopaedics, Inc. received a $613,742 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 19, 2025, with completion anticipated by August 31, 2027. The award funds development and optimization of a compliant intramedullary tibial stem designed to extend the functional longevity of revision total...
- Federal Project Grant Award Summary The University of Pennsylvania received a $229,255 project grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded on May 5, 2026, with a completion date of April 30, 2028. This research project investigates the roles of real-world shoulder biomechanics in rotator cuff tendinopathy rehabilitation, addressing the high...
- Federal Grant Award Summary The Hospital for Special Surgery Fund, Inc. (HSS Foundation) received a $267,423 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded September 16, 2025, with completion targeted for August 31, 2028. The grant funds research to develop circulating cell-free tumor DNA (ctDNA) biomarkers for assessing immunosuppressive drug...
- Federal Grant Award Summary Carnegie Mellon University received a $1,040,910 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective April 1, 2026 through March 31, 2028. The project investigates the feasibility of a smart garment—specifically a sensorized compression sleeve incorporating capacitive sensing technology embedded in e-textiles—as a...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $172,034 Project Grant to the University of Nebraska Medical Center on August 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research initiative, with a completion date of June 30, 2030, focuses on identifying molecular and epidemiologic determinants of myocardial dysfunction and heart failure (HF) in patients with...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Johns Hopkins University a $543,417 Project Grant effective June 1, 2026 through May 31, 2031 under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research initiative focuses on promoting functional neuromuscular regeneration following chronic volumetric muscle loss (VML) in aged mice. The project will deliver three primary...
- Federal Project Grant Award Summary The University of Rochester received a $547,767 project grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded on June 1, 2026, with completion targeted for May 31, 2031. This research initiative addresses host mechanisms governing Staphylococcus aureus persistence during implant-associated osteomyelitis, a major clinical...
Rush University Medical Center received a $643,185 Project Grant awarded on June 10, 2026, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The project will develop validated, patient-specific computational models to predict polyethylene (PE) wear in total shoulder arthroplasty (TSA) procedures and identify modifiable surgical, design, and rehabilitation targets to improve implant longevity. The research addresses a critical clinical need, as PE wear and implant-related failure remain leading causes of revision surgery in TSA, a procedure with growth rates exceeding hip and knee arthroplasty. The research initiative will collect shoulder motion and muscle activation data across 25 activities of daily living from both anatomic TSA and reverse TSA patients at pre-operative and post-operative timepoints, with long-term patient follow-up extending to five years. Using unsupervised machine learning to categorize patients into movement-based phenotypes, the investigators will employ a multi-scale modeling framework to estimate in vivo shoulder loading and predict wear patterns associated with mechanical failure or inflammatory-mediated osteolysis. Additionally, the project will establish histopathological markers indicative of TSA failure caused by PE wear debris. The performance period extends through April 30, 2031.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $643.2k | 6/10/26 |